Big Pharma’s Obesity Bonanza Faces New Tests

Published on 4 Nov 2024 on The Wall Street Journal

The next few months will be crucial for obesity players Eli Lilly, Novo Nordisk and Amgen.

Read the rest of the article

Start tracking your investments with Statfolio

*Stock Advisor returns as of November 4, 2024 John Mackey, former CEO of Whole Foods..., Nvidia,...

The Motley Fool · via AOL 7 Nov 2024

(NASDAQ:REGN), recently sold 1,000 shares of the company's common stock. In addition to the sale,...

Investing.com 5 Nov 2024

The next few months will be crucial for obesity players Eli Lilly, Novo Nordisk and Amgen.

The Wall Street Journal 4 Nov 2024

Technology giant NVIDIA Corp NVDA is set to join the Dow Jones Industrial Average on Nov. 8 repla...

Benzinga 4 Nov 2024

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we ar...

Insider Monkey · via Yahoo Finance 4 Nov 2024

In November 2024, it was announced that Nvidia and Sherwin-Williams would replace Intel and Dow I...

Bankrate · via Yahoo Finance 4 Nov 2024

(Bloomberg) -- Nvidia Corp., the chipmaker at the heart of the artificial intelligence boom, is...

Bloomberg · via Yahoo Finance 2 Nov 2024

Risk aversion swept across markets on Thursday as investor disappointment over third-quarter tech...

Benzinga 31 Oct 2024

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.90%

Investing.com 31 Oct 2024

The increase is attributed to ten products achieving double-digit sales growth, notably within th...

Investing.com 31 Oct 2024